Ketamine in acute phase of severe traumatic brain injury “an old drug for new uses?”
Abstract Maintaining an adequate level of sedation and analgesia plays a key role in the management of traumatic brain injury (TBI). To date, it is unclear which drug or combination of drugs is most effective in achieving these goals. Ketamine is an agent with attractive pharmacological and pharmaco...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13054-020-03452-x |
id |
doaj-bc160e2b22ff48b585cbaecae2118d9a |
---|---|
record_format |
Article |
spelling |
doaj-bc160e2b22ff48b585cbaecae2118d9a2021-01-10T12:29:47ZengBMCCritical Care1364-85352021-01-012511710.1186/s13054-020-03452-xKetamine in acute phase of severe traumatic brain injury “an old drug for new uses?”Daniel Agustin Godoy0Rafael Badenes1Paolo Pelosi2Chiara Robba3Neurointensive Care Unit, Sanatorio PasteurAnesthesiology and Surgical-Trauma Intensive Care, University Clinic HospitalAnesthesia and Intensive Care, San Martino Policlinico Hospital, IRCCS for Oncology and NeurosciencesAnesthesia and Intensive Care, San Martino Policlinico Hospital, IRCCS for Oncology and NeurosciencesAbstract Maintaining an adequate level of sedation and analgesia plays a key role in the management of traumatic brain injury (TBI). To date, it is unclear which drug or combination of drugs is most effective in achieving these goals. Ketamine is an agent with attractive pharmacological and pharmacokinetics characteristics. Current evidence shows that ketamine does not increase and may instead decrease intracranial pressure, and its safety profile makes it a reliable tool in the prehospital environment. In this point of view, we discuss different aspects of the use of ketamine in the acute phase of TBI, with its potential benefits and pitfalls.https://doi.org/10.1186/s13054-020-03452-xKetamineTraumatic brain injurySedationAgitationSecondary insultCooperative sedation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Daniel Agustin Godoy Rafael Badenes Paolo Pelosi Chiara Robba |
spellingShingle |
Daniel Agustin Godoy Rafael Badenes Paolo Pelosi Chiara Robba Ketamine in acute phase of severe traumatic brain injury “an old drug for new uses?” Critical Care Ketamine Traumatic brain injury Sedation Agitation Secondary insult Cooperative sedation |
author_facet |
Daniel Agustin Godoy Rafael Badenes Paolo Pelosi Chiara Robba |
author_sort |
Daniel Agustin Godoy |
title |
Ketamine in acute phase of severe traumatic brain injury “an old drug for new uses?” |
title_short |
Ketamine in acute phase of severe traumatic brain injury “an old drug for new uses?” |
title_full |
Ketamine in acute phase of severe traumatic brain injury “an old drug for new uses?” |
title_fullStr |
Ketamine in acute phase of severe traumatic brain injury “an old drug for new uses?” |
title_full_unstemmed |
Ketamine in acute phase of severe traumatic brain injury “an old drug for new uses?” |
title_sort |
ketamine in acute phase of severe traumatic brain injury “an old drug for new uses?” |
publisher |
BMC |
series |
Critical Care |
issn |
1364-8535 |
publishDate |
2021-01-01 |
description |
Abstract Maintaining an adequate level of sedation and analgesia plays a key role in the management of traumatic brain injury (TBI). To date, it is unclear which drug or combination of drugs is most effective in achieving these goals. Ketamine is an agent with attractive pharmacological and pharmacokinetics characteristics. Current evidence shows that ketamine does not increase and may instead decrease intracranial pressure, and its safety profile makes it a reliable tool in the prehospital environment. In this point of view, we discuss different aspects of the use of ketamine in the acute phase of TBI, with its potential benefits and pitfalls. |
topic |
Ketamine Traumatic brain injury Sedation Agitation Secondary insult Cooperative sedation |
url |
https://doi.org/10.1186/s13054-020-03452-x |
work_keys_str_mv |
AT danielagustingodoy ketamineinacutephaseofseveretraumaticbraininjuryanolddrugfornewuses AT rafaelbadenes ketamineinacutephaseofseveretraumaticbraininjuryanolddrugfornewuses AT paolopelosi ketamineinacutephaseofseveretraumaticbraininjuryanolddrugfornewuses AT chiararobba ketamineinacutephaseofseveretraumaticbraininjuryanolddrugfornewuses |
_version_ |
1724342812697165824 |